Projects per year
Personal profile
Education
- 2010 Ph.D., Graduate Institute of Medicine, Kaohsiung Medical University, Taiwan
- 2005 MS, Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Taiwan
- 2004 Bachelor, Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Taiwan
Experience
- 2022- Professor, Graduate Institute of Pharmacognosy, Taipei Medical University, Taiwan
- 2017-2022 Associate Professor, Graduate Institute of Pharmacognosy, Taipei Medical University, Taiwan
- 2016-2017 Assistant Professor, Ph.D. Program in Biotechnology Research and Development, Taipei Medical University
- 2015-2017 Assistant Professor, Ph.D. Program for Translational Medicine, Taipei Medical University
- 2012-2017 Assistant Professor, Graduate Institute of Pharmacognosy, Taipei Medical University, Taiwan
- 2010-2011 Adjunct Assistant Professor, Department and Graduate of Aquaculture, National Kaohsiung Marine University, Taiwan
Awards
- 2021 科技部吳大猷先生紀念獎_藥學領域
-
2020 國家新創獎_新創精進
- 2019 國家新創獎_學研新創
- 2012 戰國策創業競賽 (特優獎)
- 2008 National Innovation Award (The First Prize)
Fingerprint
Dive into the research topics where Kuo-Hsiang Chuang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
開發可刺激胰島beta細胞增生之拮抗型BACE-2抗體以改善第二型糖尿病(3/3)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
開發人類化拮抗型BACE-2抗體及其衍生PD-L1融合蛋白新藥之新穎胰島保護策略以全面應用於第一型與第二型糖尿病治療(1/3)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Development of Anti-Α9nachr/Anti-Cd3 Bispecific Antibody to One-Step Construct an Armed T Cell Immunotherapy for Efficiently Eliminating Breast Tumor( III )
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Development of Antagonistic Bace-2 Antibodies to Improve Type 2 Diabetes by Inducing Pancreatic Beta-Cells Proliferation( II )
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
開發串聯式人類第二型乙型轉化生長因子受體重組蛋白以去除細胞外液中乙型轉化生長因子之醫療應用
7/1/22 → 2/28/23
Project: A - Government Institution › b - National Science and Technology Council
-
A non-genetic engineering platform for rapidly generating and expanding cancer-specific armed T cells
Chen, Y. J., Chen, M., Cheng, T. L., Tsai, Y. S., Wang, C. H., Chen, C. Y., Wu, T. Y., Tzou, S. C., Wang, K. H., Cheng, J. J., Kao, A. P., Lin, S. Y. & Chuang, K. H., Dec 2023, In: Journal of Biomedical Science. 30, 1, 35.Research output: Contribution to journal › Article › peer-review
Open Access -
Comparing the Therapeutic Mechanism and Immune Response of Human and Mouse Mesenchymal Stem Cells in Immunocompetent Mice With Acute Liver Failure
Wang, C. H., Chen, C. Y., Wang, K. H., Kao, A. P., Chen, Y. J., Lin, P. H., Chen, M., Wu, T. Y., Cheng, J. J., Lee, K. D. & Chuang, K. H., Jan 30 2023, In: Stem cells translational medicine. 12, 1, p. 39-53 15 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma
Tseng, H. J., Banerjee, S., Qian, B., Lai, M. J., Wu, T. Y., Hsu, T. I., Lin, T. E., Hsu, K. C., Chuang, K. H., Liou, J. P. & Shih, J. C., Aug 2023, In: European Journal of Medicinal Chemistry. 256, 115459.Research output: Contribution to journal › Article › peer-review
-
New ent-kaurene and germacrene derivatives from Mesona procumbens Hemseley and their biological activity
Ganzon, J. G., Liaw, C. C., Lin, Y. C., Lin, Z. H., Wang, C. H., Chen, C. Y., Chuang, K. H. & Kuo, Y. H., 2023, In: Natural Product Research. 37, 13, p. 2172-2180 9 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Oct-4 induces cisplatin resistance and tumor stem cell-like properties in endometrial carcinoma cells
Lin, T. C., Wang, K. H., Chuang, K. H., Kao, A. P. & Kuo, T. C., Jan 2023, In: Taiwanese Journal of Obstetrics and Gynecology.Research output: Contribution to journal › Article › peer-review
Datasets
-
Additional file 1 of Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer
Liu, E. (Contributor), Wang, C. (Contributor), Chuang, K. (Contributor), Chen, F. (Creator), Wu, T. (Contributor), Chen, C. (Creator), Chen, I. (Creator), Lin, R. (Creator), Wang, Y. (Contributor), Lu, Y. (Contributor), Liao, T. (Contributor), Chen, H. (Creator), Cheng, T. (Creator) & Cheng, Y. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12885938.v1, https://doi.org/10.6084%2Fm9.figshare.12885938.v1
Dataset
-
Additional file 1 of A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies
Wang, Y. (Creator), Huang, B. (Creator), Hsieh, Y. (Creator), Ho, K. (Creator), Cheng, T. (Creator), Wang, J. (Creator), Liu, H. (Creator), Tsai, H. (Creator), Liao, J. (Creator), Liu, Y. (Creator), Hong, S. (Creator), Chen, I. (Creator), Su, Y. (Creator) & Chuang, K. (Creator), Figshare, 2022
DOI: 10.6084/m9.figshare.19101789.v1, https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_A_universal_in_silico_V_D_J_recombination_strategy_for_developing_humanized_monoclonal_antibodies/19101789/1
Dataset
-
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Su, C. (Contributor), Chen, M. (Contributor), Chen, L. (Contributor), Ho, Y. (Contributor), Ho, H. (Contributor), Lin, S. (Contributor), Chuang, K. (Contributor) & Sheu, M. (Contributor), Unknown Publisher, May 2 2018
DOI: 10.6084/m9.figshare.6213620.v1, https://tandf.figshare.com/articles/Bispecific_antibodies_anti-mPEG_anti-HER2_for_active_tumor_targeting_of_docetaxel_DTX_-loaded_mPEGylated_nanocarriers_to_enhance_the_chemotherapeutic_efficacy_of_HER2-overexpressing_tumors/6213620/1
Dataset
-
Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer
Cheng, Y. (Creator), Wu, T. (Contributor), Wang, Y. (Contributor), Cheng, T. (Creator), Chen, I. (Creator), Lu, Y. (Contributor), Chuang, K. (Contributor), Wang, C. (Contributor), Chen, C. (Creator), Lin, R. (Creator), Chen, H. (Creator), Liao, T. (Contributor), Liu, E. (Contributor) & Chen, F. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5105096.v1, https://springernature.figshare.com/collections/Humanized_bispecific_antibody_mPEG_HER2_rapidly_confers_PEGylated_nanoparticles_tumor_specificity_for_multimodality_imaging_in_breast_cancer/5105096/1
Dataset
-
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies
Hsieh, Y. (Creator), Liao, J. (Creator), Chuang, K. (Creator), Ho, K. (Creator), Hong, S. (Creator), Liu, H. (Creator), Huang, B. (Creator), Chen, I. (Creator), Liu, Y. (Creator), Wang, J. (Creator), Tsai, H. (Creator), Su, Y. (Creator), Wang, Y. (Creator) & Cheng, T. (Creator), Figshare, 2022
DOI: 10.6084/m9.figshare.c.5819661.v1, https://springernature.figshare.com/collections/A_universal_in_silico_V_D_J_recombination_strategy_for_developing_humanized_monoclonal_antibodies/5819661/1
Dataset